Two Seas Capital LP Ardelyx, Inc. Transaction History

Two Seas Capital LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$3.28 - $5.51 $1.91 Million - $3.2 Million	-580,921 Reduced 27.4%	1,539,416 $6.03 Million
Q1 2025 May 15, 2025	BUY	$4.91 - $6.36 $1.3 Million - $1.69 Million	265,000 Added 14.28%	2,120,337 $10.4 Million
Q4 2024 Feb 14, 2025	BUY	$4.49 - $6.85 $8.33 Million - $12.7 Million	1,855,337 New	1,855,337 $9.59 Million

246

161M

697K

1.61M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $908M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Two Seas Capital LP, based on Form 13F filings with the SEC.

Stay updated on Two Seas Capital LP with notifications on news.